Therapeutic use of calpeptin in COVID-19 infection

This perspective considers the benefits of the potential future use of the cell permeant calpain inhibitor, calpeptin, as a drug to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Recent work has reported calpeptin’s capacity to inhibit entry of the virus into cells. El...

Descripción completa

Detalles Bibliográficos
Autores principales: Inal, Jameel, Paizuldaeva, Ainura, Terziu, Esmeralda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2022
Materias:
Host-Microbe Interactions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594985/
https://www.ncbi.nlm.nih.gov/pubmed/36268783
http://dx.doi.org/10.1042/CS20220638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594985/
https://www.ncbi.nlm.nih.gov/pubmed/36268783
http://dx.doi.org/10.1042/CS20220638

Ejemplares similares